BASSAN, MERAV,EYAL, ELI,HAGAI, ESTHER LUKASIEWICZ,SVEINSDOTTER TEIGE WICKENBERG, ANNA KRISTINA
申请号：
CA2913781
公开号：
CA2913781A1
申请日:
2014.06.19
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
This invention provides a method of treating a human patient afflicted with Huntington's disease, comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine or a pharmaceutically acceptable salt thereof such that greater than 135 mg of pridopidine is administered to the patient per day. This invention further provides a method of treating a human patient afflicted with Huntington's disease, comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine hydrochloride such that greater than 90 mg of pridopidine is administered to the patient per day.
